InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by LANCASTER RONNY B, Director. Director active across 2 companies, notably ORASURE TECHNOLOGIES INC. Cumulatively, 4 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €201k. History available since 18 May 2021. The latest transaction was filed on 26 August 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
50,000 shares@ US$4.00100.0% of flowCommon StockSEC:0001062993-22-018836:0
Canonical exit: 24 Nov 2022 (T+90)
20,000 shares@ US$5.250.049% mcap36.9% of flowCommon StockSEC:0001062993-22-012897:0
10,952 shares@ US$9.587531.5% of flowCommon StockSEC:0001593968-21-001392
10,952 shares@ US$9.58750.042% mcap31.5% of flowCommon StockSEC:0001593968-21-001392:0
4 of 4 declarations
About LANCASTER RONNY B
Ronny B. Lancaster is a Director at ORASURE TECHNOLOGIES INC. He plays a key role in the governance of the company, providing his expertise to guide strategic decisions. His experience in the health technology sector enables him to contribute to innovation and sustainability.
